Oxygen Therapeutics - The Quest for Artificial Blood

Transfusion-Free Medicine and Surgery

Volumn , Issue , 2007, Pages 254-282

  Bartlett, Robert ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bovine hemoglobin; Hemoglobin based oxygen carriers; Human hb solutions; Oncotic properties; Oxygen affinity

Indexed keywords

EID: 84889628982     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470994788.ch12     Document Type: Chapter

References (96)

1. Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am 1995; 75: 257-77.
2. Zallen G, Moore EE, Ciesla DJ. Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2. Shock 2000; 13: 29-33.
3. Ghio M, Contini P, Mazzei C et al. In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion? Transfusion 2001; 41: 988-96.
4. Gould SA, Moore EE, Moore FA et al. Clinical utility of human polymerized hemoglobin as a blood substitute after acute trauma and urgent surgery. J Trauma 1997; 43: 325-32.
5. Phillips WT, Lemen L, Goins B et al. Use of oxygen-15 to measure oxygen-carrying capacity of blood substitutes in vivo. Am J Physiol 1997; 272: H2492-H2499.
6. Gulati A, Sharma AC, Singh G. Role of endothelin in the cardiovascular effects of diaspirin-crosslinkedandstroma-reducedhemoglobin. CritCareMed1996;24:137-47.
7. Hindman BJ, Dexter F, Cutkomp J et al. Diaspirin-crosslinked hemoglobin does not increase brain oxygen consumption during hypothermic cardiopulmonary bypass in rabbits. Anesthesiology 1995; 83: 1302-11.
8. Jia L, Bonaventura J, Stamler JS et al. S-nitrosohemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380: 221-6.
9. Gould SA, Moss GS. Clinical development of human polymerized hemoglobin as a blood substitute. World J Surg 1996; 20: 1200-7.
10. Matheson B, Razynaka A, Kwansa H, Bucci E. Vascular response to infusions of a nonextravasating hemoglobin polymer. J Appl Physiol 2002; 93: 1479-86.
11. Winslow RM. Alternative oxygen therapeutics: products, status of clinical trials, and future prospects. Curr Hematol Rep 2003; 2: 503-10.
12. Intaglietta M, Johnson P, Winslow R. Microvascular and tissue oxygen distribution. Cardiovasc Res 1996; 32: 632-43.
13. Homer L, Weathersby P, Kiesow L. Oxygen gradients between red blood cells in the microcirculation. Microvascular Res 1981; 22: 308-23.
14. Biro G, Anderson P, Curtis S, Cain S. Stroma-free hemoglobin: its presence in plasma does not improve oxygen supply to the resting hindlimb vascular bed of hemodiluted dogs. Can J Physiol Pharmacol 1991; 69: 1656.
15. Scholander P. Oxygen transport through hemoglobin solutions. Science 1960; 131: 585-90.
16. Vlahakes GJ, Lee R, Jacobs EE Jr et al. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thorac Cardiovasc Surg 1990; 100: 379-88.
17. Looker D, Abbott-Brown D, Cozart P, Durfee S, Hoffman S, Mathews AJ, Miller-Roehrich J, Shoemaker S, Trimble S, Fermi G, Komiyama NH, Nagai K, Stetler GL. A human recombinant haemoglobin designed for use as a blood substitute. Nature 1992; 356: 258-60.
18. Resta TC, Walker BR, Eichinger MR, Doyle MP. Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity. J Appl Physiol 2002; 93: 1327-36.
19. Sakai H, Tsai A, Rohlfs R et al. Microvascular responses to hemodilution with Hb vesicles as red blood cell substitutes: influence of O2 affinity. Am J Physiol 1999; 276: H553-H562.
20. Sakai H, Horinouchi H, Tomiyama K, Ikeda E, Takeoka S, Kobayashi K, Tsuchida E. Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system. Am J Pathol 2001; 159: 1079-88.
21. Hoag H. Blood substitute from worms shows promise: haemoglobin from sea creature could replace red cells. Nature 2003; 4 June.
22. Zal F, Lallier F, Toulmond A. Utilisation comme substitut sanguin d'une hémoglobine extracellulaire de poids moléculaire élevé . French Patent No. 00 07031, granted 2 August 2002.
23. Amberson WR, Mulder AG, Steggerda FR et al. Mammalian life without red blood corpuscles. Science 1933; 78: 106-7.
24. Amberson WR, Jennings JJ, Rhode CM. Clinical experience with hemoglobinsaline solutions. J Appl Physiol 1949; 1: 469-89.
25. Gould SA, Moore EE, Hoyt DB et al. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 1998; 187: 113-20.
26. Gould SA, Moore EE, Hoyt DB et al. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J Am Coll Surg 2002; 195; 445-52.
27. Sprung J, Kindscher JD, Wahr JA et al. The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, singleblinded trial. Anesth Analg 2002; 94: 799-808.
28. Mullon J, Giacoppe G, Clagett C et al. Brief report: transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia. N Engl J Med 2000; 342: 1638-43.
29. Chang TMS. Future generations of red blood cell substitutes. J Intern Med 2003; 253: 527-35.
30. Powanda DD, Chang TM. Cross-linked polyhemoglobin-superoxide dismutasecatalase supplies oxygen without causing blood-brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion. Artif Cells Blood Substit Immobil Biotechnol 2002; 30: 23-37.
31. Chang TM. Modified hemoglobin-based blood substitutes: cross-linked, recombinant and encapsulated hemoglobin. Vox Sang 1998; 74: 233-41.
32. Winslow RM. Alternative oxygen therapeutics: products, status of clinical trials, and future prospects. Curr Hematol Rep 2003; 6: 503-10.
33. Tsai AG, Vandegriff KD, Intaglietta M et al. Targeted O2 delivery by low-P50 hemoglobin: a new basis for O2 therapeutics. Am J Physiol Heart Circ Physiol 2003; 285: H1411-H1419.
34. Wettstein R, Tsai A, Erni D et al. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Crit Care Med 2003; 31: 1824-30.
35. Matheson B, Razynaka A, Kwansa H, Bucci E. Vascular response to infusions of a nonextravasating hemoglobin polymer. J Appl Physiol 2002; 93: 1479-86.
36. Huang Y, Komatsu T, Nakagawa A, Tsuchida E, Kobayashi S. Compatibility in vitro of albumin-heme (O2 carrier) with blood cell components. J Biomed Mater Res 2003; 66A: 292-7.
37. Zunszain PA, Ghuman J, Komatsu T, Tsuchida E, Curry S. Crystal structural analysis of human serum albumin complexed with hemin and fatty acid. BMC Struct Biol 2003; 3: 6 (Epub. 7 July 2003).
38. Simoni J, Simoni G, Wesson DE, Griswold JA, Feola M. A novel hemoglobinadenosine-glutathione based blood substitute: evaluation of its effects on human blood ex vivo. ASAIO J 2000; 46: 679-92.
39. Feola M, Simoni J, Angelillo R et al. Clinical trial of a hemoglobin-based blood substitute in patients with sickle cell anemia. Surg Gynecol Obstet 1992; 174: 379-86.
40. Spahn DR, Waschke KF, Standl T et al. Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: results of a European phase 3 study. Anesthesiology 2002; 97: 1338-49.
41. Perutz MF, Poyart C. Bezafibrate lowers oxygen affinity of haemoglobin. Lancet 1983; 2: 881-2.
42. Poyart C, Marden MC, Kister J. Bezafibrate derivatives as potent effectors of hemoglobin. Methods Enzymol 1994; 232: 496-513.
43. Wahr JA, Gerber M, Venitz J et al. Allosteric modification of oxygen delivery by hemoglobin. Anesth Analg 2001; 92: 615-20.
44. Miyake M, Grinberg OY, Hou H, Steffen RP, Elkadi H, Swartz HM. The effect of RSR13, a synthetic allosteric modifier of hemoglobin, on brain tissue PO2 (measured by EPR oximetry) following severe hemorrhagic shock in rats. Adv Exp Med Biol 2003; 530: 319-29.
45. Grinberg OY, Miyake M, Hou H, Steffen RP, Swartz HM. The dose-dependent effect of RSR13, a synthetic allosteric modifier of hemoglobin, on physiological parameters and brain tissue oxygenation in rats. Adv Exp Med Biol 2003; 530: 287-96.
46. Boerema I, Meijne NG, Brummelkamp WH et al. Life without blood. J Cardiovasc Surg 1960; 182: 133-46.
47. Hart G. Exceptional blood loss anemia: treatment with hyperbaric oxygen therapy. JAMA 1974; 228: 1028-9.
48. Hart GB. Hyperbaric oxygen in exceptional acute blood-loss anemia. J Hyperbaric Med 1987; 2: 205-10.
49. Doi Y, Onji Y.: Oxygen deficit in haemorrhagic shock under hyperbaric oxygen. Proceedings of the 4th International Congress on Hyperbaric Medicine. Japan, September 1969; 181.
50. Attar S, Esmond WG, Cowley RA. Hyperbaric oxygenation in vascular collapse. J Thor and Cardio Surg 1962; 44: 759.
51. Attar S, Esmond WG, Blair E et al. Experimental aspects of the use of hyperbaric oxygen in hemorrhagic shock. Am Surg 1964; 30: 243-6.
52. Elliott DP, Paton BC. Effect of 100% oxygen at one and three atmospheres on dogs subjected to hemorrhagic hypotension. Surgery 1965; 57: 401-8.
53. Yamashita M. Hyperbaric oxygen treatment attenuates cytokine induction after massive hemorrhage. Am J Physiol 2000; 278: 811-16.
54. Wright JK, Ehler W, McGlasson DL, Thomson W. Facilitation of recovery from acute blood loss with hyperbaric oxygen. Arch Surg 2002; 137: 850-3.
55. Spahn DR. Perioperative transfusion triggers for red blood cells. Vox Sang 2000; 78(Suppl): 163-6.
56. Shoemaker WC, Kram HB. Effects of crystalloids and colloids on hemodynamics, oxygen transport, and outcome in high-risk surgical patients. In: Simmons RL, Udekwu AO, eds. Debates in General Surgery. Chicago: Year Book Medical Publishers, 1990: 263-302.
57. Schwartz S, Frantz A, Shoemaker WC. Sequential hemodynamic and oxygen transport responses in hypovolemia, anemia, and hypoxia. Am J Physiol 1981; 241: 864-71.
58. Cone JB. Monitoring of tissue oxygenation. In: Snyder JV, Pinsky JR, eds. Oxygen Transport in the Critically Ill. ISBN 0-8151-7903-0. Chicago: Year Book Medical Publishers, 1987: 164-76.
59. Kern JW, Shoemaker WC. Meta-analysis of hemodynamic optimization in highrisk patients. Crit Care Med 2002; 30: 1686-92.
60. Baue AE. Multiple, progressive or sequential system fauilure: a syndrome of the 1970s. Arch Surg 1975; 110: 779.
61. Baue AE, Chaudry IH. Prevention of multiple systems failure. Surg Clin North Am 1980; 60: 1167-78.
62. Shoemaker WC, Appel PL, Kram HB. Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure. Crit Care Med 1988; 16: 1117-20.
63. Crowell JW, Smithe EE. Oxygen deficit and irreversible hemorrhagic shock. Am J Physiol 1964; 106: 313.
64. Shoemaker WC, Czer L, Chang P et al. Cardiorespiratory monitoring in postoperative patients - I: prediction of outcome and severity of illness. Crit Care Med 1979; 7: 237.
65. Shoemaker WC, Appel PL, Kram HB. Measurement of tissue perfusion by oxygen transport patterns in experimental shock and high-risk surgical patients. Intens Care Med 1990; 16: S135.
66. Shoemaker WC, Appel PL, Kram HB et al. Oxygen transport measurements to evaluate tissue perfusion and titrate therapy: dobutamine and dopamine effects. Crit Care Med 1991; 19: 672-88.
67. Schumacker PT, Cain SM. The concept of a critical oxygen delivery. Intens Care Med 1987; 13: 223-9.
68. Reinhart K, Hannemann L, Kuss B. Optimal oxygen delivery in critically ill patients. Intens Care Med 1990; 16(Suppl.): S149-S155.
69. Shibutani K, Komatsu T, Kubal K, Sanchala V, Kumar V, Bizzarri DV. Critical level of oxygen delivery in anesthetized man. Crit Care Med 1983; 11: 640-3.
70. Buran MJ. Oxygen consumption. In: Snyder JV, Pinsky JR, eds. Oxygen Transport in the Critically Ill. ISBN 0-8151-7903-0. Chicago: Year Book Medical Publishers, 1987: 16-23.
71. Kasnitz P, Druger GL, Yorra F et al. Mixed venous oxygen tension and hyperlactatemia. JAMA 1976; 236: 570.
72. Swan H, Sanchez M, Tyndall M, Koch C. Quality control of perfusion: monitoring venous blood oxygen tension to prevent hypoxic acidosis. J Thorac Cardiovasc Surg 1990; 99: 868-72.
73. Cain SM. Assessment of tissue oxygenation. Crit Care Med 1986; 2: 537.
74. Trouwborst A, Tenbrinck R, van Woerkens ECSM. Blood gas analysis of mixed venous blood during normoxic acute isovolemic hemodilution in pigs. Anesth Analg 1990; 70: 523-9.
75. Kuo L, Pittman RN. Effect of hemodilution on oxygen transport in arteriolar networks of hamster striated muscle. Am J Physiol 1988; 254: H331-H339.
76. Van der Hoeven MAHBM, Maertzdorf WJ, Blanco CE. Relationship between mixed venous oxygen saturation and markers of tissue oxygenation in progressive hypoxic hypoxia and in isovolemic anemic hypoxia in 8- to 12-day-old piglets. Crit Care Med 1999; 27: 1885-92.
77. Weg JG. Oxygen transport in adult respiratory distress syndrome and other acute circulatory problems: relationship of oxygen delivery and oxygen consumption. Crit Care Med 1991; 19: 650-7.
78. Dantzker DR, Foresman B, Gutierrez G. Oxygen supply and utilization relationships. Am Rev Respir Dis 1991; 143: 675.
79. Waxman K, Nolan LS, Shoemaker WC. Sequential perioperative lactate determination: physiological and clinical implications. Crit Care Med 1982; 10: 96.
80. Rashkin MC, Bosken C, Baughman RP. Oxygen delivery in critically ill patients: relationship of blood lactate and survival. Chest 1985; 87: 580-3.
81. Komatsu T, Shibutani K, Okamoto K et al. Critical level of oxygen delivery after cardiopulmonary bypass. Crit Care Med 1987; 15: 194.
82. Knudson MM, Lee S, Erickson V, Morabito D et al. Tissue oxygen monitoring during hemorrhagic shock and resuscitation: a comparison of lactated Ringer's solution, hypertonic saline dextran, and HBOC-201. J Trauma 2003; 54: 242-52.
83. Moore EE. Blood substitutes: the future is now. J Am Coll Surg 2003; 196: 1-17.
84. Standl T, Freitag M, Burmeister MA et al. Hemoglobin-based oxygen carrier HBOC-201 provides higher and faster increase in oxygen tension in skeletal muscle of anemic dogs than do stored red blood cells. J Vasc Surg 2003; 37: 859-65.
85. Spahn DR, van Brempt R, Theilmeier G, Reibold JP et al. Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group. Anesthesiology 1999; 91: 1195-208.
86. Levy JH, Goodnough LT, Greilich P et al. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 2002; 124: 35-42.
87. Hill SE, Gottschalk LI, Grichnik K. Safety and preliminary efficacy of hemoglobin raffimer for patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2002; 16: 695-702.
88. Hill SE, Leone BJ, Faithfull NS et al. Perflubron emulsion (AF0144) augments harvesting of autologous blood: a phase II study in cardiac surgery. J Cardiothorac Vasc Anesth 2002; 16: 555-60.
89. Krieter H, Hagen G, Waschke KF et al. Isovolemic hemodilution with a bovine hemoglobin-based oxygen carrier: effects on hemodynamics and oxygen transport in comparison with a nonoxygen-carrying volume substitute. J Cardiothorac Vasc Anesth 1997; 11: 3-9.
90. Schubert A, Przybelski RJ, Eidt JF et al. Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery: a multicenter, randomized, controlled, double-blinded trial. Anesth Analg 2003; 97: 323-32.
91. Levy JH. The use of haemoglobin glutamer-250 (HBOC-201) as an oxygen bridge in patients with acute anaemia associated with surgical blood loss. Exp Opin Biol Ther 2003; 3: 509-17.
92. Niquille M, Touzet M, Leblanc I, Baron JF. Reversal of intraoperative myocardial ischemia with a hemoglobin-based oxygen carrier. Anesthesiology 2000; 92: 882-5.
93. Saxena R, Wijnhoud AD, Carton H et al. Controlled safety study of a hemoglobinbased oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 1999; 30: 993-6.
94. Claudio C, Schramm S, Wettstein R et al. Improved oxygenation in ischemic hamster flap tissue is correlated with increasing hemodilution with Hb vesicles and their O2 affinity. Am J Physiol Heart Circ Physiol 2003; 285: H1140-H1147.
95. Lanzkron S, Moliterno AR, Norris EJ. Polymerized human Hb use in acute chest syndrome: a case report. Transfusion 2002; 42: 1422-7.
96. Teicher BA, Schwartz GN, Alvarez Sotomayor E et al. Oxygenation of tumors by a hemoglobin solution. J Cancer Res Clin Oncol 1993; 120: 85-90.